Year: 2020

news_6

Alteogen Enters into a Global License Agreement with a Top Ten Pharmaceutical Company for Use of Its Hybrozyme™ Technology to Enable Subcutaneous Administration of Biologic Products

Second multi-national pharma to enter into an agreement with Alteogen DAEJEON, South Korea--(BUSINESS WIRE)--#ALTB4--Alteogen Inc. (KOSDAQ:196170) announced today that it...